167 related articles for article (PubMed ID: 20227400)
1. Gastrointestinal acetylcholinesterase activity following endotracheal microinstillation inhalation exposure to sarin in guinea pigs.
Chanda S; Song J; Rezk P; Sabnekar P; Doctor BP; Sciuto AM; Nambiar MP
Chem Biol Interact; 2010 Sep; 187(1-3):309-11. PubMed ID: 20227400
[TBL] [Abstract][Full Text] [Related]
2. Treatment with endotracheal therapeutics after sarin microinstillation inhalation exposure increases blood cholinesterase levels in guinea pigs.
Che MM; Song J; Oguntayo S; Doctor BP; Rezk P; Perkins MW; Sciuto AM; Nambiar MP
Toxicol Mech Methods; 2012 May; 22(4):250-9. PubMed ID: 22145985
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs.
Che MM; Conti M; Chanda S; Boylan M; Sabnekar P; Rezk P; Amari E; Sciuto AM; Gordon RK; Doctor BP; Nambiar MP
Toxicol Appl Pharmacol; 2009 Sep; 239(3):251-7. PubMed ID: 19523969
[TBL] [Abstract][Full Text] [Related]
4. Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in Guinea pigs.
Che MM; Conti M; Boylan M; Sciuto AM; Gordon RK; Nambiar MP
Inhal Toxicol; 2008 Jul; 20(9):821-8. PubMed ID: 18645722
[TBL] [Abstract][Full Text] [Related]
5. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized scopolamine protects against microinstillation inhalation toxicity to sarin in guinea pigs.
Che MM; Chanda S; Song J; Doctor BP; Rezk PE; Sabnekar P; Perkins MW; Sciuto AM; Nambiar MP
Toxicol Mech Methods; 2011 Jul; 21(6):463-72. PubMed ID: 21651338
[TBL] [Abstract][Full Text] [Related]
7. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
[TBL] [Abstract][Full Text] [Related]
8. The effects of repeated low-dose sarin exposure.
Shih TM; Hulet SW; McDonough JH
Toxicol Appl Pharmacol; 2006 Sep; 215(2):119-34. PubMed ID: 16556454
[TBL] [Abstract][Full Text] [Related]
9. Determination of miosis threshold from whole-body vapor exposure to sarin in African green monkeys.
Genovese RF; Benton BJ; Oubre JL; Fleming PJ; Jakubowski EM; Mioduszewski RJ
Toxicology; 2008 Feb; 244(2-3):123-32. PubMed ID: 18096290
[TBL] [Abstract][Full Text] [Related]
10. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs.
Spruit HE; Langenberg JP; Trap HC; van der Wiel HJ; Helmich RB; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 2000 Dec; 169(3):249-54. PubMed ID: 11133347
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
12. Acute microinstillation inhalation exposure to sarin induces changes in respiratory dynamics and functions in guinea pigs.
Conti ML; Che MM; Boylan M; Sciuto AM; Gordon RK; Nambiar MP
Int J Toxicol; 2009; 28(5):436-47. PubMed ID: 19815847
[TBL] [Abstract][Full Text] [Related]
13. Response of rats to low levels of sarin.
Henderson RF; Barr EB; Blackwell WB; Clark CR; Conn CA; Kalra R; March TH; Sopori ML; Tesfaigzi Y; Ménache MG; Mash DC
Toxicol Appl Pharmacol; 2002 Oct; 184(2):67-76. PubMed ID: 12408950
[TBL] [Abstract][Full Text] [Related]
14. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis.
van Helden HP; Trap HC; Kuijpers WC; Oostdijk JP; Benschop HP; Langenberg JP
J Appl Toxicol; 2004; 24(1):59-68. PubMed ID: 14745848
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasmatic levels of sarin and cholinesterase inhibition in rats exposed to sarin vapors.
Sevelová L; Bajgar J; Bielavská M
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S80-2. PubMed ID: 15141989
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.
Bueters TJ; Joosen MJ; van Helden HP; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1307-13. PubMed ID: 12604711
[TBL] [Abstract][Full Text] [Related]
18. Behavioral evaluation of rats following low-level inhalation exposure to sarin.
Genovese RF; Mioduszewski RJ; Benton BJ; Pare MA; Cooksey JA
Pharmacol Biochem Behav; 2009 Feb; 91(4):517-25. PubMed ID: 18835292
[TBL] [Abstract][Full Text] [Related]
19. The dose-response effects of repeated subacute sarin exposure on guinea pigs.
Hulet SW; McDonough JH; Shih TM
Pharmacol Biochem Behav; 2002 Jul; 72(4):835-45. PubMed ID: 12062573
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
Herkert NM; Aurbek N; Eyer P; Thiermann H; Worek F
Toxicol Lett; 2010 May; 194(3):94-101. PubMed ID: 20156534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
